SOULABLA INSULIN
SOULABLA INSULIN is a medication used for managing diabetes mellitus. It contains insulin, a hormone that regulates blood sugar levels.SOULABLA INSULIN is indicated for the treatment of diabetes mellitus to control blood sugar levels.
The dosage of SOULABLA INSULIN varies depending on factors such as the patient's weight, blood sugar levels, and response to treatment. It is typically administered via subcutaneous injection. Dosage adjustments may be necessary under medical supervision.
SOULABLA INSULIN is contraindicated in patients with hypersensitivity to insulin or any of its components. It should not be used during episodes of hypoglycemia (low blood sugar) or in patients with diabetic ketoacidosis without medical supervision.
Patients using SOULABLA INSULIN should be monitored closely for signs of hypoglycemia and hyperglycemia. Dosage adjustments may be necessary during periods of illness, stress, or changes in physical activity. Caution is advised in patients with renal or hepatic impairment.
Common side effects of SOULABLA INSULIN may include injection site reactions (such as redness, swelling, or itching), hypoglycemia, weight gain, and allergic reactions. Serious side effects such as hypokalemia (low potassium levels) or lipodystrophy (fat redistribution) may occur rarely.
SOULABLA INSULIN may interact with certain medications, including oral hypoglycemic agents, beta-blockers, corticosteroids, and certain antibiotics. Close monitoring and dosage adjustments may be necessary when using SOULABLA INSULIN concomitantly with other medications.
Brand Name | Manufactured by |
---|---|
HUMINSULIN 30:70 | ELI LILLY AND COMPANY (INDIA) PVT. LTD. |